These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

941 related items for PubMed ID: 25625841

  • 1. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, Inoue T, Shiraishi E, Inoue T, Hiyama S, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T.
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [Abstract] [Full Text] [Related]

  • 2. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS, Hsu HC, Tseng KC, Chen HC, Chen SJ.
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [Abstract] [Full Text] [Related]

  • 3. Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells.
    Yi H, Cho HJ, Cho SM, Jo K, Park JA, Kim NH, Amidon GL, Kim JS, Shin HC.
    Int J Oncol; 2012 Jul; 41(1):310-6. PubMed ID: 22552503
    [Abstract] [Full Text] [Related]

  • 4. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.
    Capodanno Y, Buishand FO, Pang LY, Kirpensteijn J, Mol JA, Argyle DJ.
    Endocr Relat Cancer; 2018 Feb; 25(2):131-144. PubMed ID: 29175872
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C, Wang L, Wang H, Yang L, Guo H, Wang X.
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N, Hirata Y, Yamaguchi N, Noguchi Y, Saito M, Nagata C, Takakura S, Yamada K, Okamoto A.
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [Abstract] [Full Text] [Related]

  • 7. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M.
    Mol Cancer; 2017 Mar 07; 16(1):57. PubMed ID: 28270211
    [Abstract] [Full Text] [Related]

  • 8. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
    Garner JM, Fan M, Yang CH, Du Z, Sims M, Davidoff AM, Pfeffer LM.
    J Biol Chem; 2013 Sep 06; 288(36):26167-26176. PubMed ID: 23902772
    [Abstract] [Full Text] [Related]

  • 9. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
    Jin Y, Wang M, Hu H, Huang Q, Chen Y, Wang G.
    Int J Biol Macromol; 2018 Oct 01; 117():445-453. PubMed ID: 29852230
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
    Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M.
    Nutrients; 2018 Jul 12; 10(7):. PubMed ID: 30002278
    [Abstract] [Full Text] [Related]

  • 11. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, Chang SC, Teng HW, Yang SH, Lan YT, Chiou SH, Wang HW.
    Gastroenterology; 2011 Jul 12; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [Abstract] [Full Text] [Related]

  • 12. Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.
    Kang MJ, Kim HP, Lee KS, Yoo YD, Kwon YT, Kim KM, Kim TY, Yi EC.
    Proteomics; 2013 May 12; 13(10-11):1714-25. PubMed ID: 23554123
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F, Sun H, Zhang S, Yang X, Zhang G, Su T.
    Oncol Res; 2017 May 24; 25(5):709-719. PubMed ID: 27983919
    [Abstract] [Full Text] [Related]

  • 14. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
    Huang R, Wang G, Song Y, Tang Q, You Q, Liu Z, Chen Y, Zhang Q, Li J, Muhammand S, Wang X.
    Mol Med Rep; 2015 Aug 24; 12(2):2417-24. PubMed ID: 25936357
    [Abstract] [Full Text] [Related]

  • 15. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV, Yang D, Lu C, Redd PS, Choi JH, Heaton CM, Lee JR, Nayak-Kapoor A, Liu K.
    Oncotarget; 2016 Nov 29; 7(48):78698-78712. PubMed ID: 27659530
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133+ cells to vincristine and 5-fluorouracil through upregulation of BBC3.
    Hemati H, Kaur J, Sobti RC, Trehanpati N.
    Biochem Biophys Res Commun; 2020 May 14; 525(4):941-947. PubMed ID: 32173531
    [Abstract] [Full Text] [Related]

  • 17. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS, Huang PI, Chang YL, Tzao C, Chen YW, Shih HC, Hung SC, Chen YC, Tseng LM, Chiou SH.
    Cancer; 2011 Jul 01; 117(13):2970-85. PubMed ID: 21225866
    [Abstract] [Full Text] [Related]

  • 18. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
    Nayak A, Das S, Nayak D, Sethy C, Narayan S, Kundu CN.
    Cell Oncol (Dordr); 2019 Apr 01; 42(2):157-171. PubMed ID: 30603978
    [Abstract] [Full Text] [Related]

  • 19. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
    Wu W, Cao J, Ji Z, Wang J, Jiang T, Ding H.
    Oncotarget; 2016 Dec 06; 7(49):81144-81155. PubMed ID: 27835894
    [Abstract] [Full Text] [Related]

  • 20. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S, Tian J, Zhang H, Zhou S, Wang X, Zhang L, Yang J, Zhang Z, Ji Z.
    Apoptosis; 2018 Jun 06; 23(5-6):356-374. PubMed ID: 29777330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.